22 employees
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
2012
$13M
from 2 investors over 2 rounds
Viking Therapeutics, Inc. raised $13M on August 25, 2016
Investors: Aspire Capital Partners, LLC
Viking Therapeutics, Inc. raised $2.5M on May 26, 2014
Investors: Pharmacopeia now Ligand Pharmaceuticals